Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults?

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Therapeutic Advances in Urology Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI:10.1177/17562872241290723
Jennifer King, Nancy Tuders, Susann Varano, Janet Owens-Grillo
{"title":"Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults?","authors":"Jennifer King, Nancy Tuders, Susann Varano, Janet Owens-Grillo","doi":"10.1177/17562872241290723","DOIUrl":null,"url":null,"abstract":"<p><p>What is this summary about? This is a plain language summary of an article published in the journal <i>Clinical Pharmacology in Drug Development</i>. It is about a study of a medicine called <b>vibegron</b>. <b>Vibegron</b> is approved by the US Food and Drug Administration (also called the FDA) to treat overactive bladder, also known as OAB. It may be easier for people with swallowing issues to take a pill by crushing it and mixing it with applesauce instead of swallowing it whole. Researchers did this study to find out if <b>vibegron</b> could be safely crushed and mixed with applesauce. Participants took <b>vibegron</b> that was either crushed or intact, and researchers compared how much <b>vibegron</b> made it into the bloodstream over time. The researchers asked whether people who took crushed <b>vibegron</b> had more unwanted medical events (called adverse events) than people who took <b>vibegron</b> as an intact pill. What were the results? Crushed <b>vibegron</b> tablets did not change in applesauce for 4 h at room temperature. Just over half of the participants (53%) said that the taste was not different than expected. The amount of <b>vibegron</b> in blood over time was similar between those who took crushed <b>vibegron</b> and those who took intact <b>vibegron</b>. The most common adverse events were headache, constipation, and nausea. No participant experienced a serious adverse event during the study, meaning that no adverse events required hospital care or caused permanent damage or disability. Adverse events that might be related to <b>vibegron</b> occurred in seven participants (23%) after they took crushed <b>vibegron</b> and six participants (20%) after they took the intact pill. What do the results mean? The results of this study show that <b>vibegron</b> can be crushed and taken with applesauce without increases in adverse events compared to taking the intact pill. Crushed <b>vibegron</b> did not change in applesauce and the amount of <b>vibegron</b> in blood over time was similar when <b>vibegron</b> was crushed in applesauce or taken whole. This means that people may take <b>vibegron</b> as a crushed or intact pill for overactive bladder. This may be particularly important for people with difficulty swallowing. Who should read this article? This article is for people with overactive bladder symptoms who have a hard time swallowing pills. It may also be helpful for their families and care partners, and for health care professionals who care for people with overactive bladder. Where can I find the original article on which this summary is based? The original article is called \"Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy Adults.\" You can read the original article published in <i>Clinical Pharmacology in Drug Development</i> at this link: • https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.1169.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"16 ","pages":"17562872241290723"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622284/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872241290723","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

What is this summary about? This is a plain language summary of an article published in the journal Clinical Pharmacology in Drug Development. It is about a study of a medicine called vibegron. Vibegron is approved by the US Food and Drug Administration (also called the FDA) to treat overactive bladder, also known as OAB. It may be easier for people with swallowing issues to take a pill by crushing it and mixing it with applesauce instead of swallowing it whole. Researchers did this study to find out if vibegron could be safely crushed and mixed with applesauce. Participants took vibegron that was either crushed or intact, and researchers compared how much vibegron made it into the bloodstream over time. The researchers asked whether people who took crushed vibegron had more unwanted medical events (called adverse events) than people who took vibegron as an intact pill. What were the results? Crushed vibegron tablets did not change in applesauce for 4 h at room temperature. Just over half of the participants (53%) said that the taste was not different than expected. The amount of vibegron in blood over time was similar between those who took crushed vibegron and those who took intact vibegron. The most common adverse events were headache, constipation, and nausea. No participant experienced a serious adverse event during the study, meaning that no adverse events required hospital care or caused permanent damage or disability. Adverse events that might be related to vibegron occurred in seven participants (23%) after they took crushed vibegron and six participants (20%) after they took the intact pill. What do the results mean? The results of this study show that vibegron can be crushed and taken with applesauce without increases in adverse events compared to taking the intact pill. Crushed vibegron did not change in applesauce and the amount of vibegron in blood over time was similar when vibegron was crushed in applesauce or taken whole. This means that people may take vibegron as a crushed or intact pill for overactive bladder. This may be particularly important for people with difficulty swallowing. Who should read this article? This article is for people with overactive bladder symptoms who have a hard time swallowing pills. It may also be helpful for their families and care partners, and for health care professionals who care for people with overactive bladder. Where can I find the original article on which this summary is based? The original article is called "Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy Adults." You can read the original article published in Clinical Pharmacology in Drug Development at this link: • https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.1169.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
本摘要是关于什么的?这是发表在《药物开发中的临床药理学》(Clinical Pharmacology in Drug Development)杂志上的一篇文章的简明摘要。它是关于一种名为 Vibegron 的药物的研究。美国食品和药物管理局(也称 FDA)批准 Vibegron 用于治疗膀胱过度活动症,也称为 OAB。对于有吞咽问题的人来说,将药片碾碎并与苹果酱混合服用可能比整个吞服更容易。研究人员进行了这项研究,以了解将 vibegron 碾碎并与苹果酱混合是否安全。研究人员比较了随着时间的推移有多少维贝琼进入血液。研究人员询问,与服用完整药片的人相比,服用碾碎的维贝琼的人是否会发生更多不必要的医疗事件(称为不良事件)。结果如何?压碎的维贝琼药片在室温下的苹果酱中 4 小时内没有变化。略高于半数的参与者(53%)表示,味道与预期的并无不同。随着时间的推移,服用碾碎的维贝琼和服用完整维贝琼的人血液中的维贝琼含量相似。最常见的不良反应是头痛、便秘和恶心。研究期间没有参与者发生严重不良事件,这意味着没有不良事件需要住院治疗或造成永久性损伤或残疾。有七名参与者(23%)在服用碾碎的威百亩后发生了可能与威百亩有关的不良事件,有六名参与者(20%)在服用完整的威百亩后发生了可能与威百亩有关的不良事件。研究结果意味着什么?这项研究的结果表明,与服用完整药片相比,将维贝琼碾碎后与苹果酱一起服用不会增加不良反应。碾碎的维贝琼在苹果酱中的含量没有变化,而且随着时间的推移,维贝琼在血液中的含量与在苹果酱中碾碎或整个服用时的含量相似。这就意味着,人们可以通过服用压碎的或完整的药片来治疗膀胱过度活动症。这对于吞咽困难的人来说可能尤为重要。谁应该阅读本文?本文适用于膀胱过度活动症患者,他们吞咽药片有困难。对于他们的家人和护理伙伴,以及护理膀胱过度活动症患者的医护人员来说,这篇文章可能也会有所帮助。在哪里可以找到本摘要所依据的原文?原文名为 "健康成人服用完整或压碎片剂的威贝琼 75 毫克的药代动力学和安全性"。您可以通过以下链接阅读发表在《药物开发中的临床药理学》上的原文:- https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.1169。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
期刊最新文献
Metaverse surgical planning for robotic surgery: preliminary experience and users' perception. Traumatic ureteral injury: an initial outcome and experience. HoloLens® platform for healthcare professionals simulation training, teaching, and its urological applications: an up-to-date review. Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults? Comparison of surgical outcomes of endoscopic enucleation of the prostate using different energies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1